Goldman Sachs Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $48
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $48.
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $48.